Telik, Inc.
Get Full AccessDescription
- An innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. The companys most advanced investigational drug candidates in clinical development are TELINTRA® (Ezatiostat HCl, TLK199) for the treatment of cytopenias due to myelodysplastic syndrome or chemotherapy, and TELCYTA® (Canfosfamide HCl, TLK286) for the treatment of advanced ovarian cancer and non-small cell lung cancer. Teliks product candidates were discovered using its proprietary drug discovery technology, TRAP®, which enables the rapid and efficient discovery of small molecule drug candidates.
-
Headquarters:2100 Geng Road Suite 102, Palo Alto, California, United States
More -
Phone Number: +1 650-845-7700
-
Website: https://www.telik.com
-
Employees:17
-
Revenue:$10 - 50M
-
Legal Name:Telik, Inc.
-
Telik, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Telik, Inc.
-
Where are Telik, Inc.'s Headquarters?
Telik, Inc.'s Headquarters are in 2100 Geng Road Suite 102,Palo Alto,California,United States
-
What is Telik, Inc.'s phone number?
Telik, Inc.'s phone number is +1 650-845-7700
-
What is Telik, Inc.'s official website?
Telik, Inc.'s official website is https://www.telik.com
-
What is Telik, Inc.'s Revenue?
Telik, Inc.'s revenue is $10 - 50M
-
What is Telik, Inc.'s NAICS code?
Telik, Inc.'s NAICS code is 541713
-
How many employees are working in Telik, Inc.
Telik, Inc. has 17 employees
-
What is Telik, Inc.'s Industry?
Telik, Inc. is in the industry of Biotechnology
-
Who is Telik, Inc.'s Chief Operations Officer And Chief Financial Officer?
Telik, Inc.'s Chief Operations Officer And Chief Financial Officer is Cynthia Butitta